REVisiting Antibody structures and repertoires through advances in Mass spectrometry and Proteomics

REVAMP aims to develop innovative mass spectrometry techniques to comprehensively analyze the structural and functional diversity of human antibody repertoires, enhancing our understanding of immune responses.

Subsidie
€ 2.500.000
2025

Projectdetails

Introduction

In REVAMP, I will create innovative structural mass spectrometry (MS) and proteomics techniques to generate an unprecedented molecular understanding of the diversity and structural and functional characteristics of human antibody repertoires. These repertoires are highly personal and play a key role in our human immune response.

Research Focus

Recently, my research has taken a novel challenging avenue, with a focus on the development of cutting-edge MS-based techniques to better understand antibody structure and function. With these methods, I have started to monitor at the protein level changes in endogenous antibody repertoires with clonal resolution, including those induced by antigen-specific polyclonal responses in individuals.

Expansion of Techniques

Early studies were limited to IgG1, and in REVAMP, I aim to expand the toolbox to the full antibody repertoire, including all (sub)classes of antibodies. I aim to learn how and why antibody profiles in serum and other body fluids are alike or distinct, investigating:

  1. Structural differences
  2. Clonal differences
  3. Functional differences over time and between individuals

Targeting Sub-Repertoires

I will develop technologies to target the sub-repertoires recognizing antigens from pathogens. Following identification by advanced top-down and bottom-up de novo sequencing, these antibodies will be followed up functionally as potential therapeutic leads.

Special Attention to IgM

Special attention will be given to IgM, the largest human antibody, appearing first in the response to an antigen. We recently made the preliminary striking observation that its structure is ill-defined in textbooks, and that human IgM may be quite different from IgM in other mammals.

Methodological Advances

This project will benefit from our recent advances in structural analysis by:

  • Single molecule mass spectrometry
  • Mass photometry
  • Atomic force microscopy
  • Electron microscopy

Conclusion

REVAMP will overhaul our current view of the structural diversity of our human antibody repertoire and thereby elevate our understanding of how the human immune system functions.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 2.500.000

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • UNIVERSITEIT UTRECHTpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

In situ structural biology of human immune defence

Developing super-resolution cryo-correlative light and electron microscopy (SRcryoCLEM) to enhance in situ structural biology for antibody-mediated immunity and therapeutic advancements.

€ 1.976.553
ERC Advanced...

Computational design of synthetic antibody repertoires for accelerated therapeutic discovery

CADABRE aims to design and optimize diverse human antibody repertoires with enhanced stability and developability for therapeutic discovery using advanced protein design and AI-driven screening methods.

€ 2.741.000
ERC Consolid...

Learning the interaction rules of antibody-antigen binding

This project aims to enhance antibody-antigen binding prediction by generating large-scale sequence and structural data through high-throughput screening and machine learning techniques.

€ 2.000.000
ERC Starting...

Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection

This project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats.

€ 1.486.245
ERC Starting...

Deciphering the antibody-microbiota axis in early life

This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.

€ 1.650.000

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

From A to BCR: B-Cell Receptor Repertoire Profiling for Antibody Development

Dit project ontwikkelt een geïntegreerde B-cel repertoire sequentiëringstechnologie om sneller en beter antilichamen te identificeren voor nieuwe geneesmiddelen en therapieën tegen kanker.

€ 153.020
EIC Pathfinder

Human Antibody-enabled Cardiovascular Personalized Theranosis

ABCardionostics aims to develop a multi-marker PET/MRI system using human antibodies to personalize treatment and improve diagnosis of atherosclerosis in vulnerable patients.

€ 3.639.665
EIC Transition

Predictive REagent-Antibody Replacement Technology stage 2-Translation

PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.

€ 800.000